Interview: Michelle Lock – Biopharmaceutical Vice President & General Manager, Bristol Myers Squibb, Switzerland

michelle-lock-pic2Michelle Lock describes the positive challenges that come with expanding a biopharmaceutical business that possesses a well-regarded pipeline, and that continuously launches products across the Alpine region. She highlights the strategic importance of the region for Bristol Myers Squibb, and the increasing focus on securing market access. What are the responsibilities for a vice president in biopharmaceuticals at BMS?
"A critical component of working in pharmaceuticals is ensuring that patients can gain access to medicines. Patients remain at the center of what we are doing at BMS."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report